PLAP for Treating Bone Marrow Toxicity

Cancer therapies are generally toxic to the bone marrow. Using relevant animal models, we have demonstrated that PLAP can greatly reduce therapy induced loss of platelets as well as red and white blood cells primarily by protecting their blood stem cell precursors.

The combined positive effects of PLAP on cachexia and bone marrow health will allow the use of higher doses of cancer therapies with greater frequency resulting in longer survival, or even a cure, of the cancer patient.